← Leaderboards
Kazukuni Hayashi
Cedars-Sinai Medical Center
$264,961
Attributed
$264,961
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $75.5K · FY2020–25$100K$75K$50K$25K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$264,961 · 2
By mechanism
F32$149,348 · 1
F31$115,613 · 1
Top collaborators
No co-investigators on record.
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Stephen L. Shiao$2,835,837
- Mitchell Kronenberg$46,508,740
- Vashisht G Yennu Nanda$998,215
- Bin Zheng$7,982,696
- Yong J Lee$5,697,287
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsCancer CellActivities Of Daily LivingImmuneInfiltrationT-LymphocyteNeoplastic CellClinical TrialsChemotherapyClustered Regularly Interspaced Short Palindromic RepeatsCd8-Positive T-LymphocytesCheckpoint TherapyClinical ApplicationClinically RelevantCasp1 GeneCell DeathAblationBaseBiologyCancer TypeAnti-CancerCancer ModelAnti-Inflammatory AgentsAnabolism
Grant awards (5)
Reprogramming Antigen Presenting Cells in Lymph Nodes to Overcome Tumor Immune Tolerance$75,520
F32 · FY2025 · CA · contact PI
Reprogramming Antigen Presenting Cells in Lymph Nodes to Overcome Tumor Immune Tolerance$73,828
F32 · FY2024 · CA · contact PI
Regulation of inhibitory DAMP to harness immunogenic cell death$24,057
F31 · FY2022 · CA · contact PI
Regulation of inhibitory DAMP to harness immunogenic cell death$46,036
F31 · FY2021 · CA · contact PI
Regulation of inhibitory DAMP to harness immunogenic cell death$45,520
F31 · FY2020 · CA · contact PI